The Ezra Blueprint scan reportedly includes quantitative brain measurements, coronary calcium scoring (CAC) and a full-body MRI that provides screening for over 500 conditions.
Offering a combination of 3T magnetic resonance imaging (MRI) and computed tomography (CT) that can provide fatty liver assessment, lung cancer screening and aneurysm detection with two hour-long appointments, Ezra has launched the Ezra Blueprint scan.
The Ezra Blueprint scan reportedly includes neurodegenerative assessment with brain MRI, artificial intelligence (AI)-powered quantification of subcutaneous fat and MRI angiography for possible diagnosis of brain aneurysm and carotid artery disease, according to Ezra, the developer of the Ezra Blueprint.
The newly launched Ezra Blueprint scan reportedly combines 3T MRI and CT for full-body scanning that facilitates screening for over 500 conditions. (Images courtesy of Ezra.)
Other features included in the Ezra Blueprint are high-resolution imaging of knee and hip joints, CT-based coronary calcium scoring (CAC) and full-body MRI that enables screening of over 500 conditions, according to Ezra.
After two 60-minute appointments to complete Ezra Blueprint scanning, Ezra said patients will subsequently receive a detailed radiology report and a consultation review by medical providers associated with Ezra.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.